fig1

The role of immune checkpoint inhibitors in triple-negative breast cancer: recent developments and future perspectives

Figure 1. CD80/86:CTLA-4 interactions and CTL-4 blockade with monoclonal antibodies.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/